dromlakhani Against vitamin D supplementation in adults under 50
STEP 1 — Gather Information
Collect patient age, pregnancy status, presence of established indications for vitamin D treatment or testing (e.g., hypocalcemia, malabsorption, CKD stage 4‑5, osteoporosis with fracture), current vitamin D intake from diet and supplements, and sun exposure habits.
STEP 2 — Rule In / Rule Out
If patient is ≥50 years, pregnant, or has an established indication for vitamin D treatment/testing → Stop; guideline does not apply. Otherwise, proceed to assess supplementation needs.
STEP 3 — Classify or Stratify
Determine if current vitamin D intake exceeds the Dietary Reference Intake (DRI) for age group (600 IU daily for ages 19‑70, 800 IU for >70). Classify as "exceeding DRI" or "at/below DRI".
STEP 4 — Decide
For "exceeding DRI": advise stopping excess supplementation to align with DRI. For "at/below DRI": advise against initiating empiric vitamin D supplementation beyond DRI; maintain current intake if adequate.
Clinical Guardrails / Mimics / Pitfalls
Do not order routine 25(OH)D testing; do not prescribe high‑dose intermittent vitamin D; do not assume benefit for non‑skeletal outcomes (e.g., CVD, cancer, mortality) in this population; do not extrapolate to patients with malabsorption, CKD, osteoporosis, or other established indications; do not replace DRI with higher doses without a specific indication.
Concrete Clinical Example
A 35‑year‑old non‑pregnant woman presents with fatigue and asks if she should start vitamin D. She reports adequate sun exposure, consumes fortified milk daily, takes no supplements, and has no indications for vitamin D. She is classified as at/below DRI. Advise against empiric supplementation beyond DRI; maintain current diet and sun exposure.
Source: Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290